150 related articles for article (PubMed ID: 11127819)
21. Human Papillomavirus 16 (HPV-16), HPV-18, and HPV-31 E6 Override the Normal Phosphoregulation of E6AP Enzymatic Activity.
Thatte J; Banks L
J Virol; 2017 Nov; 91(22):. PubMed ID: 28835500
[TBL] [Abstract][Full Text] [Related]
22. The role of protein kinase A regulation of the E6 PDZ-binding domain during the differentiation-dependent life cycle of human papillomavirus type 18.
Delury CP; Marsh EK; James CD; Boon SS; Banks L; Knight GL; Roberts S
J Virol; 2013 Sep; 87(17):9463-72. PubMed ID: 23804647
[TBL] [Abstract][Full Text] [Related]
23. Involvement of a cellular ubiquitin-protein ligase E6AP in the ubiquitin-mediated degradation of extensive substrates of high-risk human papillomavirus E6.
Matsumoto Y; Nakagawa S; Yano T; Takizawa S; Nagasaka K; Nakagawa K; Minaguchi T; Wada O; Ooishi H; Matsumoto K; Yasugi T; Kanda T; Huibregtse JM; Taketani Y
J Med Virol; 2006 Apr; 78(4):501-7. PubMed ID: 16482544
[TBL] [Abstract][Full Text] [Related]
24. HPV E6 and MAGUK protein interactions: determination of the molecular basis for specific protein recognition and degradation.
Thomas M; Glaunsinger B; Pim D; Javier R; Banks L
Oncogene; 2001 Sep; 20(39):5431-9. PubMed ID: 11571640
[TBL] [Abstract][Full Text] [Related]
25. Restoration of MAGI-1 expression in human papillomavirus-positive tumor cells induces cell growth arrest and apoptosis.
Kranjec C; Massimi P; Banks L
J Virol; 2014 Jul; 88(13):7155-69. PubMed ID: 24696483
[TBL] [Abstract][Full Text] [Related]
26. The high-risk HPV E6 oncoprotein preferentially targets phosphorylated nuclear forms of hDlg.
Narayan N; Subbaiah VK; Banks L
Virology; 2009 Apr; 387(1):1-4. PubMed ID: 19307009
[TBL] [Abstract][Full Text] [Related]
27. Binding of high-risk human papillomavirus E6 oncoproteins to the human homologue of the Drosophila discs large tumor suppressor protein.
Kiyono T; Hiraiwa A; Fujita M; Hayashi Y; Akiyama T; Ishibashi M
Proc Natl Acad Sci U S A; 1997 Oct; 94(21):11612-6. PubMed ID: 9326658
[TBL] [Abstract][Full Text] [Related]
28. Interactions of the PDZ-protein MAGI-1 with adenovirus E4-ORF1 and high-risk papillomavirus E6 oncoproteins.
Glaunsinger BA; Lee SS; Thomas M; Banks L; Javier R
Oncogene; 2000 Nov; 19(46):5270-80. PubMed ID: 11077444
[TBL] [Abstract][Full Text] [Related]
29. Solution structure of the hDlg/SAP97 PDZ2 domain and its mechanism of interaction with HPV-18 papillomavirus E6 protein.
Liu Y; Henry GD; Hegde RS; Baleja JD
Biochemistry; 2007 Sep; 46(38):10864-74. PubMed ID: 17713926
[TBL] [Abstract][Full Text] [Related]
30. Role of the PDZ domain-binding motif of the oncoprotein E6 in the pathogenesis of human papillomavirus type 31.
Lee C; Laimins LA
J Virol; 2004 Nov; 78(22):12366-77. PubMed ID: 15507623
[TBL] [Abstract][Full Text] [Related]
31. Cellular steady-state levels of "high risk" but not "low risk" human papillomavirus (HPV) E6 proteins are increased by inhibition of proteasome-dependent degradation independent of their p53- and E6AP-binding capabilities.
Kehmeier E; Rühl H; Voland B; Stöppler MC; Androphy E; Stöppler H
Virology; 2002 Jul; 299(1):72-87. PubMed ID: 12167343
[TBL] [Abstract][Full Text] [Related]
32. Comparison of human papillomavirus type 18 (HPV-18) E6-mediated degradation of p53 in vitro and in vivo reveals significant differences based on p53 structure and cell type but little difference with respect to mutants of HPV-18 E6.
Gardiol D; Banks L
J Gen Virol; 1998 Aug; 79 ( Pt 8)():1963-70. PubMed ID: 9714244
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of E6-induced degradation of its cellular substrates by novel blocking peptides.
Sterlinko Grm H; Weber M; Elston R; McIntosh P; Griffin H; Banks L; Doorbar J
J Mol Biol; 2004 Jan; 335(4):971-85. PubMed ID: 14698292
[TBL] [Abstract][Full Text] [Related]
34. Structural insights into a wildtype domain of the oncoprotein E6 and its interaction with a PDZ domain.
Mischo A; Ohlenschläger O; Hortschansky P; Ramachandran R; Görlach M
PLoS One; 2013; 8(4):e62584. PubMed ID: 23638119
[TBL] [Abstract][Full Text] [Related]
35. The human papillomavirus (HPV) E6* proteins from high-risk, mucosal HPVs can direct degradation of cellular proteins in the absence of full-length E6 protein.
Pim D; Tomaic V; Banks L
J Virol; 2009 Oct; 83(19):9863-74. PubMed ID: 19640984
[TBL] [Abstract][Full Text] [Related]
36. Cancer-causing human papillomavirus E6 proteins display major differences in the phospho-regulation of their PDZ interactions.
Boon SS; Tomaić V; Thomas M; Roberts S; Banks L
J Virol; 2015 Feb; 89(3):1579-86. PubMed ID: 25410862
[TBL] [Abstract][Full Text] [Related]
37. Characterization of PDZ-binding kinase, a mitotic kinase.
Gaudet S; Branton D; Lue RA
Proc Natl Acad Sci U S A; 2000 May; 97(10):5167-72. PubMed ID: 10779557
[TBL] [Abstract][Full Text] [Related]
38. Human papillomavirus (HPV) E6 interactions with Bak are conserved amongst E6 proteins from high and low risk HPV types.
Thomas M; Banks L
J Gen Virol; 1999 Jun; 80 ( Pt 6)():1513-1517. PubMed ID: 10374970
[TBL] [Abstract][Full Text] [Related]
39. Regulation of the human papillomavirus oncoproteins by differential phosphorylation.
Massimi P; Pim D; Kühne C; Banks L
Mol Cell Biochem; 2001 Nov; 227(1-2):137-44. PubMed ID: 11827165
[TBL] [Abstract][Full Text] [Related]
40. Phosphorylation of the discs large tumour suppressor protein controls its membrane localisation and enhances its susceptibility to HPV E6-induced degradation.
Massimi P; Narayan N; Cuenda A; Banks L
Oncogene; 2006 Jul; 25(31):4276-85. PubMed ID: 16532034
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
